The Claim
A reduction in LDL cholesterol by 1.0 mmol/L through statin therapy reduces the risk of major vascular events by 21% in individuals with a 5-year risk of vascular disease below 10%, including those without prior vascular disease, diabetes, or chronic kidney disease, and this reduction directly prevents heart attacks, strokes, and revascularizations regardless of baseline risk level.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Lowering LDL cholesterol by 1.0 mmol/L with statin therapy reduces the risk of heart attacks, strokes, and revascularizations by 21% in people with low baseline vascular risk, including those without prior heart disease, diabetes, or kidney disease.
See the scientific wording
Lowering LDL cholesterol by 1.0 mmol/L with statin therapy reduces the risk of major vascular events by 21% in individuals with a 5-year risk of vascular disease below 10%, including those without prior vascular disease, diabetes, or chronic kidney disease, demonstrating that LDL reduction directly prevents heart attacks, strokes, and revascularizations regardless of baseline risk level.
Lowering LDL cholesterol stops fatty deposits from building up inside artery walls, which prevents those deposits from cracking and triggering blood clots that block blood flow to the heart or brain.
What the research says
1 studyTaking statins to lower LDL cholesterol by 1 point reduces the chance of heart attacks, strokes, or artery surgeries by about 21% even in people with very low risk of heart disease—meaning it helps even if they’ve never had a heart problem before.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.